Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Gronwald

Showing results (171-180 of 307) with videos related to

Pageof 31
Sort By:
Gynecologic Oncology|August 22, 2024
Incidence of endometrial cancer in BRCA mutation carriersJoanne Kotsopoulos, Jan Lubinski, Tomasz Huzarski, et al.
Gynecologic Oncology|August 10, 2025
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variantAdriana I Apostol, Joanne Kotsopoulos, Jacek Gronwald, et al.
Cancer|December 26, 2022
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?Kelly A Metcalfe, Jacek Gronwald, Nadine M Tung, et al.
European Journal of Human Genetics : EJHG|December 2, 2010
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populationsNancy Hamel, Bing-Jian Feng, Lenka Foretova, et al.
Breast Cancer Research and Treatment|June 22, 2014
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriersJacek Gronwald, Andre Robidoux, Charmaine Kim-Sing, et al.
Biological Trace Element Research|July 11, 2020
Lung Cancer Occurrence-Correlation with Serum Chromium Levels and GenotypesPiotr Baszuk, Beata Janasik, Sandra Pietrzak, et al.
Breast Care (Basel, Switzerland)|June 15, 2022
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk FactorsRita K Schmutzler, Björn Schmitz-Luhn, Bettina Borisch, et al.
Breast Cancer Research and Treatment|April 17, 2008
Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathologyJan Lubiński, Marcin Korzeń, Bohdan Górski, et al.
Contemporary Oncology (Poznan, Poland)|February 19, 2015
Selenium as a marker of cancer risk and of selection for control examinations in surveillanceMarcin Lener, Magdalena Muszyńska, Anna Jakubowska, et al.
Nature Genetics|April 28, 2015
Germline RECQL mutations are associated with breast cancer susceptibilityCezary Cybulski, Jian Carrot-Zhang, Wojciech Kluźniak, et al.
Pageof 31

Showing results (171-180 of 307) with videos related to

Sort By:
Pageof 31
Gynecologic Oncology|August 22, 2024
Incidence of endometrial cancer in BRCA mutation carriersJoanne Kotsopoulos, Jan Lubinski, Tomasz Huzarski, et al.
Gynecologic Oncology|August 10, 2025
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variantAdriana I Apostol, Joanne Kotsopoulos, Jacek Gronwald, et al.
Cancer|December 26, 2022
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?Kelly A Metcalfe, Jacek Gronwald, Nadine M Tung, et al.
European Journal of Human Genetics : EJHG|December 2, 2010
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populationsNancy Hamel, Bing-Jian Feng, Lenka Foretova, et al.
Breast Cancer Research and Treatment|June 22, 2014
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriersJacek Gronwald, Andre Robidoux, Charmaine Kim-Sing, et al.
Biological Trace Element Research|July 11, 2020
Lung Cancer Occurrence-Correlation with Serum Chromium Levels and GenotypesPiotr Baszuk, Beata Janasik, Sandra Pietrzak, et al.
Breast Care (Basel, Switzerland)|June 15, 2022
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk FactorsRita K Schmutzler, Björn Schmitz-Luhn, Bettina Borisch, et al.
Breast Cancer Research and Treatment|April 17, 2008
Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathologyJan Lubiński, Marcin Korzeń, Bohdan Górski, et al.
Contemporary Oncology (Poznan, Poland)|February 19, 2015
Selenium as a marker of cancer risk and of selection for control examinations in surveillanceMarcin Lener, Magdalena Muszyńska, Anna Jakubowska, et al.
Nature Genetics|April 28, 2015
Germline RECQL mutations are associated with breast cancer susceptibilityCezary Cybulski, Jian Carrot-Zhang, Wojciech Kluźniak, et al.
Pageof 31